ASSESSMENT OF KNOWLEDGE AND UTILIZATION OF INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA AMONG PREGNANT WOMEN ATTENDING ANTENATAL CLINIC IN JIGAWA STATE, NIGERIA

  • Type: Project
  • Department: Epidemic and Community Health
  • Project ID: ECH0001
  • Access Fee: ₦5,000 ($14)
  • Pages: 94 Pages
  • Format: Microsoft Word
  • Views: 1K
  • Report This work

For more Info, call us on
+234 8130 686 500
or
+234 8093 423 853

Malaria remains the most devastating human parasitic infection in the world today.  it has been estimated that between 1-2 billion people throughout the world lives in areas at risk of malarial infection and each year up to 500 million people contract the disease out of which 1.7 million to 2.7 million people die.  Several recent reports indicate that more than 90% of these causalities are from Africa, south of the sahara where the most virulent species of the parasite Plasmodium Falciparum thrives.  Malaria is hyper endemic in all parts of Nigeria, which lies in the tropical region of Africa, with the entire population of an estimated one hundred and sixty million at risk. Transmission occurs all year round with seasonal variations during the rainy season. Malaria is the number one cause of morbidity in Nigeria accounting for ninety percent of all out-patient illnesses, sixty percent of all admissions and thirty-three percent of all deaths in children under five years. 

TABLE OF CONTENTS page

ATTESTATION ......................................................................................................................................... iii

CERTIFICATION ...................................................................................................................................... iv

DEDICATION ............................................................................................................................................. v

ACKNOWLEDGMENTS ........................................................................................................................... vi

TABLE OF CONTENTS ........................................................................................................................... vii

LIST OF TABLES ...................................................................................................................................... xi

LIST OF ACRONYMS ............................................................................................................................. xiii

SUMMARY ............................................................................................................................................... xv

DEFINITION OF TERMS ....................................................................................................................... xvii

CHAPTER ONE .......................................................................................................................................... 1

INTRODUCTION ....................................................................................................................................... 1

1.1 Background Information ......................................................................................................................... 1

1.2 Problem Statement .............................................................................................................................. 4

1.3 Justification ........................................................................................................................................ 6

1.4 Research Questions ............................................................................................................................. 7

1.5 General Objectives and Specific Objectives ....................................................................................... 7

1.5.1 General objectives ............................................................................................................................ 7

1.5.2 Specific objectives ........................................................................................................................... 7

CHAPTER TWO ......................................................................................................................................... 8

LITERATURE REVIEW ............................................................................................................................. 8

2.1 Malaria Overview of Malaria in Pregnancy ........................................................................................ 8

2.2 Malaria Transmission .......................................................................................................................... 8

2.3 Life cycle of malaria parasites ............................................................................................................ 9

............................................................................................................................................................... 10

2.4 Epidemiology of Malaria .................................................................................................................. 11

2.4.1 Group susceptible to malaria.......................................................................................................... 12

2.5 Consequences of Malaria in Pregnancy ............................................................................................ 12

2.6 Current Practices in Preventing Malaria in Pregnancy in Nigeria .................................................... 13

2.7 Overview of Intermittent Preventive Treatment for Malaria (IPTp)................................................. 14

2.8 Safety of Sulfadoxine-Pyrimethamine .............................................................................................. 14

2.9 Use of SP for Intermittent Preventive Treatment .............................................................................. 15

2.10 Determining Gestational Age for SP Administration ..................................................................... 15

2.11 Dosage of SP .................................................................................................................................. 16

2.12 Gestational Age at First ANC Visit ................................................................................................ 17

2.13 Knowledge on Malaria .................................................................................................................... 18

2.14 Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) ............................................... 19

2.15 Knowledge of Intermittent Preventive Treatment of Malaria in Pregnancy (IPTp) ....................... 20

2.16 Factors that influence IPT Utilization ............................................................................................. 21

CHAPTER THREE ................................................................................................................................... 23

METHODOLOGY .................................................................................................................................... 23

3.1 Study Area ....................................................................................................................................... 23

3.2 Study Designs .................................................................................................................................. 24

3.3 Study Population ............................................................................................................................... 24

3.3.1 Inclusion Criteria ........................................................................................................................... 24

3.3.2 Exclusion Criteria .......................................................................................................................... 25

3.4 Sample Size Determination ............................................................................................................... 26

3.5 Sampling Technique ......................................................................................................................... 27

3.6 Study Instruments ............................................................................................................................. 30

3.7 Data Collection Methods .................................................................................................................. 30

3.8 Data Management ............................................................................................................................. 31

3.8.1 Measurement of variables .............................................................................................................. 31

3.8.1.1 The independent variables: ......................................................................................................... 31

3.8.1.2. Dependent variables ................................................................................................................... 31

Use of IPTp (IPT Utilization) ................................................................................................................. 31

3.8.2 Statistical Analyses ........................................................................................................................ 32

3.9 Ethical Considerations ...................................................................................................................... 33

3.10 Limitations ..................................................................................................................................... 33

CHAPTER FOUR ...................................................................................................................................... 35

RESULTS .................................................................................................................................................. 35

4.1: Socio-demographic characteristics .................................................................................................. 35

4.2 Gestational Age at First ANC Booking ............................................................................................ 37

4.3 Knowledge of Malaria ...................................................................................................................... 38

4.4 Knowledge of IPTp ........................................................................................................................... 41

4.5 Utilization of SP among the studied subjects .................................................................................... 45

Table 10: Multi Variable Analysis of some Determinants 0f IPT immunization ....................................... 49

CHAPTER FIVE ....................................................................................................................................... 50

DISCUSSION ............................................................................................................................................ 50

CHAPTER SIX: CONCLUSION AND RECOMMENDATIONS ............................................................ 55

6.1 CONCLUSION ................................................................................................................................ 55

6.2 RECOMMENDATION .................................................................................................................... 56

REFERENCES .......................................................................................................................................... 57

APPENDICES ........................................................................................................................................... 67

Appendix 1: Questionnaire ..................................................................................................................... 67

Map of Nigeria showing Jigawa State .................................................................................................... 76

ASSESSMENT OF KNOWLEDGE AND UTILIZATION OF INTERMITTENT PREVENTIVE TREATMENT FOR MALARIA AMONG PREGNANT WOMEN ATTENDING ANTENATAL CLINIC IN JIGAWA STATE, NIGERIA
For more Info, call us on
+234 8130 686 500
or
+234 8093 423 853

Share This
  • Type: Project
  • Department: Epidemic and Community Health
  • Project ID: ECH0001
  • Access Fee: ₦5,000 ($14)
  • Pages: 94 Pages
  • Format: Microsoft Word
  • Views: 1K
Payment Instruction
Bank payment for Nigerians, Make a payment of ₦ 5,000 to

Bank GTBANK
gtbank
Account Name Obiaks Business Venture
Account Number 0211074565

Bitcoin: Make a payment of 0.0005 to

Bitcoin(Btc)

btc wallet
Copy to clipboard Copy text

500
Leave a comment...

    Details

    Type Project
    Department Epidemic and Community Health
    Project ID ECH0001
    Fee ₦5,000 ($14)
    No of Pages 94 Pages
    Format Microsoft Word

    Related Works

    Malaria remains the most devastating human parasitic infection in the world today. it has been estimated that between 1-2 billion people throughout the world lives in areas at risk of malarial infection and each year up to 500 million people contract the disease out of which 1.7 million to 2.7 million people die. Several recent reports indicate... Continue Reading
    TABLE OF CONTENTS ABSTRACT.................................................................................................................................... 1 DECLARATION ............................................................................................................................ ii APPROVAL... Continue Reading
    ABSTRACT The study was conducted in Gombe local government from September-October 2014.the research was aimed at determining the effectiveness of sulphadoxine pyrimethamine in relation to malaria prevalence among pregnant women. 156 pregnant women attending antenatal clinic at some selected maternities were for used for the research. Blood samples... Continue Reading
    ABSTRACT Background: Malaria in pregnancy increases the risk of anemia, stillbirths, spontaneous abortion, premature delivery and low birth weight. Despite preventive measures put in place, rates of malaria in pregnancy and poor birth outcomes remain persistently high in many parts of Africa. This study was aimed at determining the prevalence of... Continue Reading
    TABLE OF CONTENTS ABSTRACT............................................................................................................................................i © Copyright: Ahurra Miriam, 2017....................................................................................................ii... Continue Reading
    ABSTRACT The purpose of this study was to assess the compliance to use of intermittent preventive therapy (IPTp) against malaria among pregnant women attending antenatal clinic at the University of Calabar Teaching Hospital (UCTH), Calabar Cross River State, Nigeria. In order to accomplish this purpose, three specific objectives were formulated... Continue Reading
    ABSTRACT The purpose of this study was to assess the compliance to use of intermittent preventive therapy (IPTp) against malaria among pregnant women attending antenatal clinic at the University of Calabar Teaching Hospital (UCTH), Calabar Cross River State, Nigeria. In order to accomplish this purpose, three specific objectives were formulated... Continue Reading
    ABSTRACT Antenatal care is named one of the pillars of safe motherhood, early and frequent attendance of antenatal care during pregnancy is important to identify and control risks factors in pregnancy. However many women in sub-Saharan Africa start antenatal care late and do not complete the recommended visits by WHO. Therefore they don’t fully... Continue Reading
    Abstract This study assessed knowledge and attitude of pregnant women towards antenatal exercises (ANEx). Methods. The cross-sectional study recruited 189 pregnant women from six selected antenatal clinics in Ile-Ife, South-West, Nigeria. Data were obtained on... Continue Reading
    ABSTRACT The study on anaemia in pregnancy is aimed at determining packed cell volume (PCV), Haemoglobin (Hb) level and Erythrocyte sedimentation rate (ESR) of pregnant women, as well as the selferity, significance of maternal, age, educational level, occupation and gestational age to the occurrence of anaemia in pregnancy managed, diagnosed and... Continue Reading
    Call Us
    Get this work
    whatsappWhatsApp Us